KV Pharmaceutical Co. CL A News - KV.A | ADVFN

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NYSE
KV Pharmaceutical Co. CL A (KV.A)
KV Pharmaceutical Co. CL A (KV.A) News

KV Pharmaceutical Co. CL A (KV.A)

0.32

0.00

(0.00%)

Closed July 23 4:00PM

Delayed by 15 minutes

0.32

0.00

( 0.00% )

Pre Market: 8:00PM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

FDA Issues Further Guidance About Makena®

FDA Issues Further Guidance About Makena® FDA recommends healthcare providers prescribe FDA-approved Makena first-line for clinically-indicated...

K-V Pharmaceutical Company Announces Notification from NYSE Regarding Listing Criteria

K-V Pharmaceutical Company Announces Notification from NYSE Regarding Listing Criteria PR Newswire ST. LOUIS, June 29, 2012 ST. LOUIS, June 29...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

- Small Company Offering and Sale of Securities Without Registration (D)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM D OMB APPROVAL OMB Number: 3235-0076 Estimated Average...

FDA and CMS Issue Important Updates on Makena®

FDA and CMS Issue Important Updates on Makena® FDA Emphasizes That it is Applying its Normal Enforcement Policies for Compounded Drugs to...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market Activity

K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market Activity PR Newswire ST. LOUIS, May 25, 2012 ST...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Intesa Sanpaolo

BNP Paribas Issuance

Societe Generale

Personal Assets

Ubs Etf Lu Msci United K...

Delayed Upgrade Clock